Gene Query: SIAH1

Dataset Description Geneva Score
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 130.63
124.35
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 110.2
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 77.13
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 77.13
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 61.75
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 55.94
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 48.01
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 47.35
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 36.79
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 20.41
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 19.63
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 16.97
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 15.22
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 14.88
TOP2B disturbed the quality of human oocytes with advanced maternal age 13.91
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 13.2
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 13.2
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 12.15
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 12.05
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 11.93
Primary human trophoblast from term placenta 11.17
Paxillin regulates genomic networks in prostate cancer [LNCaP] 10.77
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 10.64
Transcriptome analysis of virus infected tissues 9.96
U1 snRNP telescripting regulates size-function stratified human genome 9.55
Landscape of H3K4me3 in human CD19 cells 9.29
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 8.94
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 8.92
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 8.58
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 8.05
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 7.34
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 7.31
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 7.2
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 7.2
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 7.1
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.61
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 6.5
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 6.24
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.85
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.85
Illumina Total RNA-seq in HeLa 5.73
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 5.71
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.67
Comparing gene expression in iPSC derived RPE from control and AMD donors 5.56
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.55
RNA sequencing of GlyH-101-treated MCF-7 cell line 5.45
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 5.37
Expression charcaterization of an internal protocol developed to differentiate RPE cells 5.21
AR-independent prostate cancer is sustained through FGF signaling 5.1
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 5.03
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 5.01
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.96
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 4.89
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 4.88
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 4.88
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 4.79
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 4.78
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.76
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 4.73
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 4.62
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.53
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 4.52
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.48
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.48
RNA-seq analysis to identify the genes regulated by p53-SET interplay 4.47
Transcriptional profile in human S. haematobium infection 4.45
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 4.27
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 4.22
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 4.22
Neonatal and adult human testis defined at the single-cell level 4.14
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 4.11
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 4.08
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 3.8
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.77
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.77
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.73
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.7
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 3.62
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.56
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.56
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.48
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.47
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 3.45
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 3.4
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.37
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 3.35
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.35
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 3.29
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 3.28
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 3.28
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 3.27
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 3.24
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 3.24
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.24
SLIGRL-induced gene expression changes in NHEK cells 3.22
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 3.22
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 3.22
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.19
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.19
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.18
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 3.14
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.12
Transciptomic profiling of human fetal lung samples 3.11
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.08
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 3.06
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.03
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.03
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.02
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.02
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.01
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 3.0
Global gene expression profile of dasatinib-resistant RCH-ACV cells 2.99
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 2.97
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 2.95
The evolution of N6-methyladenosine in primates 2.95
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 2.93
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 2.91
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.88
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 2.85
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.79
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 2.78
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 2.78
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 2.76
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.76
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.76
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.75
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 2.75
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 2.75
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.74
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.74
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 2.74
Gene expression analysis of dengue-infected cells 2.74
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.74
RNA-Sequencing of HepG2 cells treated with TGFBeta 2.72
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 2.69
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 2.69
Intron retention induced by microsatellite expansions as a disease biomarker. 2.69
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.69
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.69
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.69
Gene expression profiling of leukemia cells following asparagine depletion 2.65
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.64
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 2.64
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.63
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.63
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 2.63
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 2.63
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 2.62
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 2.62
PTHrP overexpression in MCF7 cells 2.6
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.6
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.6
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.6
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.58
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 2.58
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.57
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.56
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.56
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 2.55
TT-Seq captures the human transient transcriptome 2.54
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 2.53
LNCaP treated with iBET 2.53
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.52
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 2.48
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.46
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 2.44
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.44
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.43
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.42
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.42
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.42
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 2.41
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.39
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.38
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.38
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.36
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 2.35
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 2.35
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 2.34
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 2.34
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.33
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.33
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.33
Mapping interactions for the TNIP2 hub protein 2.33
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 2.31
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.31
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 2.31
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.3
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 2.29
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 2.29
Primary Human B-cell Temporal Response to CD40L Stimulation 2.27
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.27
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 2.27
Single-cell analysis of human kidney organoids 2.26
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.26
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 2.24
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 2.24
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.23
Targeted enhancer activation by a subunit of the integrator complex 2.23
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.22
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.22
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.21
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.21
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.21
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 2.16
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 2.16
Gene expression in GBM with Cav3.2 inhibition 2.15
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 2.14
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.12
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.11
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.11
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 2.08
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.08
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.08
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.07
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.07
Noncoding regions are the main source of targetable tumor-specific antigens 2.06
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.06
HNRNPM-regulated splicing dependencies in prostate cancer 2.06
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.05
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.05
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.04
Genome-wide analysis of the Integrator complex (HTS) 2.04
Genome-wide analysis of the Integrator complex 2.04
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 2.02
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.01
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 1.98
RNA polymerase in pre-B-ALL cell lines 1.98
The transcriptome and chromatin accessbility landscape of mammalian germline 1.96
SF3B1 Degron knockdown RNA-seq 1.96
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.95
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.95
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.95
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.94
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.94
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.94
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.94
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.92
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.9
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 1.88
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.88
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.87
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.87
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.86
Landscape and variation of RNA secondary structure across the human transcriptome 1.86
Transcriptional profiling of microglia; current state of the art and future perspectives 1.85
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 1.85
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 1.85
HNRNPL and its RNA Targets in Prostate Cancer 1.85
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.84
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.84
Effect of drugs on transcriptomic profiles 1.84
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.82
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.82
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 1.81
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 1.81
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.81
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 1.79
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 1.79
Novel Targeting of Transcription and Metabolism in Glioblastoma 1.79
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.78
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.76
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.74
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.74
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.72
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.71
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.71
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 1.71
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 1.69
Gene expression profile of human placenta from T. Cruzi infected mothers 1.68
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.67
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.67
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.67
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.67
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.67
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.65
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.65
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.64
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 1.62
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 1.61
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.61
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.6
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.59
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.59
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.59
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.58
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 1.56
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.56
Identification of HOXB13 target genes responsive to BET inhibitors 1.52
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.52
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.48
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.47
Determining mRNA half-lives on a transcriptome-wide scale 1.47
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.46
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.46
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.44
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.42
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.42
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.42
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.41
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.41
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.41
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.37
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.37
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.34
In vitro modeling of human germ cell development using pluripotent stem cells 1.34
Disruption of GRIN2B impairs differentiation in human neurons 1.34
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.34
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 1.3
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.3
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 1.29
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.28
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.28
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.28
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.26
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.26
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.24
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.24
DRB/GRO-Seq -/+ UV 1.23
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.22
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.18
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.15
quanTIseq: quantifying immune contexture of human tumors 1.15
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.15
The pause-initiation limit restricts transcription activation in human cells 1.11
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.1
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.1
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.09
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 1.07
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.07
AMPK signaling for naïve pluripotency 1.06
AMPK signaling for naïve pluripotency [Hs] 1.06
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.04
Depicting early human development and germ cell origin with porcine embryos 1.04
Microglia innatly develop within cerebral organoids 1.04
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 1.03
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 1.03
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.03
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.02
LIN28A Over-expression RNAseq 0.99
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.99
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.99
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.99
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.98
LINE-2 transposable elements are a source of functional human microRNAs and target sites 0.98
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.94
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.94
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.93
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.93
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.92
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.92
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.92
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.9
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.9
Interaction between mitoNEET and NAF-1 in cancer cells 0.89
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.87
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.86
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.85
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.84
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.84
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.84
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 0.84
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 0.84
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.83
Role of FGFR1 in neuronal devlopment 0.83
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.82
Identification of global XBP1s target gene expression in human prostate cancer cells 0.79
The DPYSL2 gene connects mTOR and schizophrenia 0.78
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.76
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 0.76
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.76
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.75
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.75
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.75
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.74
RNA-seq analysis of differentiating human erythroblasts 0.74
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.74
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.74
Analyses of T-ALL (COG study) 0.73
RNA sequencing of T-ALL (COG study) 0.73
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.73
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 0.73
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 0.71
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.71
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.7
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.69
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.69
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.68
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.68
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.68
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.67
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.66
Gene expression activation in CLL mediated by MSCs contact 0.66
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.63
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.61
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.6
RNA-seq analysis of uveal melanoma cells treated with FR900359 0.59
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.58
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.58
CD74 role in transcription regulation 0.58
CD74 role in transcription regulation [RNA-seq] 0.58
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.58
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.57
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.57
Single-cell analysis of adult human ovary using 10X genomics 0.56
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.55
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.52
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.5
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.5
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.5
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.49
Total RNA-Seq data from leukemic patients with complex structural variants 0.49
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.49
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.49
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.49
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.49
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.48
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.48
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.47
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.47
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.46
Gene expression analysis upon mtDNA depletion 0.46
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.46
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.45
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 0.45
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 0.45
Direct Isolation and Characterization of Human Nephron Progenitors. 0.44
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 0.44
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.43
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.43
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.43
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.43
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.42
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.41
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 0.41
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.4
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.4
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.4
Specific molecular signatures underlie response to decitabine in CMML 0.4
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.4
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.4
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.4
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.38
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 0.37
Leucegene: AML sequencing (part 6) 0.35
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.33
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.32
Discovering human diabetes-risk gene function with genetics and physiological assays 0.32
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.31
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.31
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.3
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.29
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.28
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.27
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.26
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.26
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.26
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.25
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.25
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.25
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.25
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 0.24
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.24
Trans-differentiation of human adult peripheral blood T cells into neurons 0.23
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.2
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.19
Transcriptional landscape changes during human embryonic stem cell derivation 0.19
Gene expression changes due to PARP knockdown in human cells 0.19
The role of CFTR in islet function 0.18
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.17
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.17
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.16
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.16
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.15
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.14
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.12
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.1
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.1
Energy Metabolism during Anchorage-Independence 0.09
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.08
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.08
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.07
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 0.06
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.05
RNA-seq of primary patient AML samples 0.04
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.04
KSDM1b Role in Ewing Sarcoma 0.04
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.04
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.04
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 0.04
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.03
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.03
Transcriptome analysis of BAP1 knockout and restoration 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.02
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.02
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.01
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.01
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation